Vascular-targeting activity of ZD6126, a novel tubulin-binding agent

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1534-1537

  Micheletti, Gianluca ^a   Poli, Maura ^a   Borsotti, Patrizia ^a   Martinelli, Michele ^a   Imberti, Barbara ^a   Taraboletti, Giulia ^a   Giavazzi, Raffaella ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; COLCHICINE DERIVATIVE; MATRIGEL; N ACETYLCOLCHINOL; N ACETYLCOLCHINOL PHOSPHATE; TUBULIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DRUG ACTIVITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STRESS FIBER; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELLS, CULTURED; COLCHICINE; CYTOSKELETON; ENDOTHELIUM, VASCULAR; HUMANS; LUNG; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; ORGANOPHOSPHORUS COMPOUNDS; TUBULIN;

EID: 0037382380     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Carmeliet, P., and Jain, R. K. Angiogenesis in cancer and other diseases. Nature, 407: 249-257, 2000.
2. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
3. Benezra, R., Rafii, S., and Lyden, D. The Id proteins and angiogenesis. Oncogene, 20: 8334-8341, 2001.
4. Chaplin, D. J., and Dougherty, G. J. Tumour vasculature as a target for cancer therapy. Br. J. Cancer, 80 (Suppl 1): 57-64, 1999.
5. Brown, J. M., and Giaccia, A. J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res., 58: 1408-1416, 1998.
6. Ruoslahti, E. Targeting tumor vasculature with homing peptides from phage display. Semin. Cancer Biol., 10: 435-442, 2000.
7. St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., and Kinzler, K. W. Genes expressed in human tumor endothelium. Science, 289: 1197-1202, 2000.
8. Taraboletti, G., and Margosio, B. Antiangiogenic and antivascular therapy for cancer. Curr. Opin. Pharmacol., 1: 378-384, 2001.
9. Halin, C., Zardi, L., and Neri, D. Antibody-based targeting of angiogenesis. News Physiol. Sci., 16: 191-194, 2001.
10. Kolonin, M., Pasqualini, R., and Arap, W. Molecular addresses in blood vessels as targets for therapy. Curr. Opin. Chem. Biol., 5: 308-313, 2001.
11. Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., and Taraboletti, G. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin. Cancer Res., 2: 1843-1849, 1996.
12. Taraboletti, G., Micheletti, G., Rieppi, M., Poli, M., Turatto, M., Rossi, C., Borsotti, P., Roccabianca, P., Scanziani, E., Nicoletti, M. I., Bombardelli, E., Morazzoni, P., Riva, A., and Giavazzi, R. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative. Clin. Cancer Res., 8: 1182-1188, 2002.
13. Miller, K. D., Sweeney, C. J., and Sledge, G. W., Jr. Redefining the target: chemotherapeutics as antiangiogenics. J. Clin. Oncol., 19: 1195-1206, 2001.
14. Griggs, J., Metcalfe, J. C., and Hesketh, R. Targeting tumour vasculature: the development of combretastatin A4. Lancet Oncol., 2: 82-87, 2001.
15. Blakey, D. C., Westwood, F. R., Walker, M., Hughes, G. D., Davis, P. D., Ashton, S. E., and Ryan, A. J. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clin. Cancer Res., 8: 1974-1983, 2002.
16. Ingber, D. E. Opposing views on tensegrity as a structural framework for understanding cell mechanics. J. Appl. Physiol., 89: 1663-1670, 2000.
17. Krendel, M., Zenke, F. T., and Bokoch, G. M. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat. Cell Biol., 4: 294-301, 2002.
18. Kanthou, C., and Tozer, G. M. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood, 99: 2060-2069, 2002.
19. Siemann, D. W., and Rojiani, A. M. Enhancement of radiation therapy by the novel vascular targeting agent ZD6126. Int. J. Radiat. Oncol. Biol. Phys., 53: 164-171, 2002.
20. Kang, G. J., Getahun, Z., Muzaffar, A., Brossi, A., and Hamel, E. N-acetylcolchinol O-methyl ether and thiocolchicine, potent analogs of colchicine modified in the C ring. Evaluation of the mechanistic basis for their enhanced biological properties. J. Biol. Chem., 265: 10255-10259, 1990.